Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 583

1.
2.

Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies.

Prasad KN.

Expert Rev Anticancer Ther. 2003 Dec;3(6):903-15. Review.

PMID:
14686711
3.

High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy.

Prasad KN, Kumar A, Kochupillai V, Cole WC.

J Am Coll Nutr. 1999 Feb;18(1):13-25. Review.

PMID:
10067654
4.

Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies.

Prasad KN, Cole WC, Kumar B, Prasad KC.

J Am Coll Nutr. 2001 Oct;20(5 Suppl):450S-463S; discussion 473S-475S. Review.

PMID:
11603656
5.

Pros and cons of antioxidant use during radiation therapy.

Prasad KN, Cole WC, Kumar B, Che Prasad K.

Cancer Treat Rev. 2002 Apr;28(2):79-91. Review.

PMID:
12297116
6.

Dietary antioxidants and human cancer.

Borek C.

Integr Cancer Ther. 2004 Dec;3(4):333-41. Review.

PMID:
15523104
7.

Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants?

Moss RW.

Integr Cancer Ther. 2006 Mar;5(1):63-82. Review.

PMID:
16484715
8.

Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1.

Simone CB 2nd, Simone NL, Simone V, Simone CB.

Altern Ther Health Med. 2007 Jan-Feb;13(1):22-8. Review.

PMID:
17283738
9.

Antioxidants and cancer therapy: furthering the debate.

Block KI.

Integr Cancer Ther. 2004 Dec;3(4):342-8. Review.

PMID:
15523105
10.

Optimal management strategies for rhabdomyosarcoma in children.

Walterhouse D, Watson A.

Paediatr Drugs. 2007;9(6):391-400. Review.

PMID:
18052409
11.

Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2.

Simone CB 2nd, Simone NL, Simone V, Simone CB.

Altern Ther Health Med. 2007 Mar-Apr;13(2):40-7. Review.

PMID:
17405678
12.

Use of antioxidants during chemotherapy and radiotherapy should be avoided.

D'Andrea GM.

CA Cancer J Clin. 2005 Sep-Oct;55(5):319-21. Review.

13.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
14.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
15.

The therapy of infantile malignant brain tumors: current status?

Kalifa C, Grill J.

J Neurooncol. 2005 Dec;75(3):279-85. Review.

PMID:
16195802
16.

Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.

Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR.

J Pain Symptom Manage. 2004 Dec;28(6):548-56.

PMID:
15589080
17.

Targeting angiogenesis with integrative cancer therapies.

Yance DR Jr, Sagar SM.

Integr Cancer Ther. 2006 Mar;5(1):9-29. Review.

PMID:
16484711
18.

The use of antioxidant therapies during chemotherapy.

Drisko JA, Chapman J, Hunter VJ.

Gynecol Oncol. 2003 Mar;88(3):434-9. Review.

PMID:
12648599
19.

Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB.

J Natl Cancer Inst. 2008 Jun 4;100(11):773-83. doi: 10.1093/jnci/djn148. Epub 2008 May 27. Review.

PMID:
18505970
20.

Antioxidants and cancer therapy: a systematic review.

Ladas EJ, Jacobson JS, Kennedy DD, Teel K, Fleischauer A, Kelly KM.

J Clin Oncol. 2004 Feb 1;22(3):517-28. Review.

PMID:
14752075

Supplemental Content

Support Center